0.00 (0.00%) 1d

Just four years, this traded at $2, and over $8 last April. It's had 3 CEOs in 18 months, but it was a viable cancer franchise that could be a huge business in a couple years. Gilead announced it was buying it today for $88. Immunomedics shot up nearly 98%.

Pharma & Healthcare
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Immonumedics(IMMU-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Immonumedics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Immonumedics(IMMU-Q) Frequently Asked Questions

What is Immonumedics stock symbol?

Immonumedics is a American stock, trading under the symbol IMMU-Q on the NASDAQ (IMMU). It is usually referred to as NASDAQ:IMMU or IMMU-Q

Is Immonumedics a buy or a sell?

In the last year, there was no coverage of Immonumedics published on Stockchase.

Is Immonumedics a good investment or a top pick?

Immonumedics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Immonumedics.

Why is Immonumedics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Immonumedics worth watching?

In the last year 0 stock analysts on Stockchase covered Immonumedics. The stock is worth watching.

What is Immonumedics stock price?

On 2020-10-22, Immonumedics (IMMU-Q) stock closed at a price of $87.86.